The renewal means DPUK will receive a further £7.5m from the MRC, with up to £8.5m from partners, in support of its aims. DPUK’s mission is to accelerate progress in dementia research by identifying the early signs of disease and supporting the translation of scientific discoveries into potential new treatments and preventive strategies.
Professor John Gallacher, Director of DPUK , said,
‘We are delighted to be able to confirm our renewed MRC funding, which means that many more scientists will have access to the technology, support and research resources needed to transform our understanding of dementia.
For more information about the Dementias Platform UK.